Interleukin-12 induces sustained activation of multiple host inflammatory mediator systems in chimpanzees

被引:53
作者
Lauw, FN
Dekkers, PEP
te Velde, AA
Speelman, P
Levi, M
Kurimoto, M
Hack, CE
van Deventer, SJH
van der Poll, T
机构
[1] Univ Amsterdam, Lab Expt Intern Med, Dept Inf Dis Trop Med AIDS, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Ctr Hemost Thromb Atheroscler & Inflam Res, NL-1105 AZ Amsterdam, Netherlands
[3] Netherlands Red Cross, Blood Transfus Serv, Cent Lab, Amsterdam, Netherlands
[4] Netherlands Red Cross, Blood Transfus Serv, Cent Lab, Dept Pathophysiol Plasma Prot, Amsterdam, Netherlands
[5] Fujisaki Inst, Hayashibara Biochem Labs, Okayama, Japan
关键词
D O I
10.1086/314636
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To determine in vivo effects of interleukin (IL)-12 on host inflammatory mediator systems, 4 healthy chimpanzees received recombinant human IL-12 (1 mu g/kg) by intravenous injection, IL-12 induced increases in plasma concentrations of IL-15, IL-18, and interferon-gamma (IFN-gamma), plus a marked antiinflammatory cytokine response (IL-10, soluble tumor necrosis factor[TNF] receptors, IL-1 receptor antagonist) and secretion of alpha-chemokines (IL-8, IFN-gamma-inducible protein 10) and beta-chemokines (monocyte chemoattractant protein-1, macrophage inflammatory protein-1 beta). In addition, IL-12 elicited neutrophilic leukocytosis, neutrophil degranulation (elastase-alpha(1)-antitrypsin complexes), coagulation activation (F1 + 2 prothrombin fragment, thrombin-antithrombin III complexes), and fibrinolytic activation (tissue-type plasminogen activator, plasmin-alpha(2)-antiplasmin complexes). IL-12-induced activation of multiple host mediator systems was found only after 8-24 h, remained detectable until the end of the 48-h observation period, and occurred in the absence of detectable TNF and IL-1 beta. These data may contribute to understanding the role of IL-12 in the pathogenesis of sepsis syndrome and the toxicity found after repeated injections of IL-12.
引用
收藏
页码:646 / 652
页数:7
相关论文
共 43 条
[31]   Characterization of anti-human interleukin-18 (IL-18)/interferon-gamma-inducing factor (IGIF) monoclonal antibodies and their application in the measurement of human IL-18 by ELISA [J].
Taniguchi, M ;
Nagaoka, K ;
Kunikata, T ;
Kayano, T ;
Yamauchi, H ;
Nakamura, S ;
Ikeda, M ;
Orita, K ;
Kurimoto, M .
JOURNAL OF IMMUNOLOGICAL METHODS, 1997, 206 (1-2) :107-113
[32]   ANTI-CACHECTIN TNF MONOCLONAL-ANTIBODIES PREVENT SEPTIC SHOCK DURING LETHAL BACTEREMIA [J].
TRACEY, KJ ;
FONG, Y ;
HESSE, DG ;
MANOGUE, KR ;
LEE, AT ;
KUO, GC ;
LOWRY, SF ;
CERAMI, A .
NATURE, 1987, 330 (6149) :662-664
[33]  
TRINCHIERI G, 1995, AM J PATHOL, V147, P1534
[35]   DIFFERENTIAL-EFFECTS OF ANTITUMOR NECROSIS FACTOR MONOCLONAL-ANTIBODIES ON SYSTEMIC INFLAMMATORY RESPONSES IN EXPERIMENTAL ENDOTOXEMIA IN CHIMPANZEES [J].
VANDERPOLL, T ;
LEVI, M ;
VANDEVENTER, SJH ;
TENCATE, H ;
HAAGMANS, BL ;
BIEMOND, BJ ;
BULLER, HR ;
HACK, CE ;
TENCATE, JW .
BLOOD, 1994, 83 (02) :446-451
[36]   ACTIVATION OF COAGULATION AFTER ADMINISTRATION OF TUMOR-NECROSIS-FACTOR TO NORMAL SUBJECTS [J].
VANDERPOLL, T ;
BULLER, HR ;
TENCATE, H ;
WORTEL, CH ;
BAUER, KA ;
VANDEVENTER, SJH ;
HACK, CE ;
SAUERWEIN, HP ;
ROSENBERG, RD ;
TENCATE, JW .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (23) :1622-1627
[37]  
vanderPoll T, 1997, BLOOD, V89, P3727
[38]   RELEASE OF SOLUBLE RECEPTORS FOR TUMOR-NECROSIS-FACTOR IN CLINICAL SEPSIS AND EXPERIMENTAL ENDOTOXEMIA [J].
VANDERPOLL, T ;
VANLEENEN, D ;
VONDERMOHLEN, M ;
LEVI, M ;
TENCATE, H ;
GALLATI, H ;
TENCATE, JW ;
VANDEVENTER, JH .
JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (04) :955-960
[39]  
vanderPoll T, 1996, BLOOD, V88, P922
[40]  
vanderPoll T, 1997, J IMMUNOL, V158, P1971